Table 2.
Demographic features of the four groups.
Control | DM | DPN | DN | R2 | ||
---|---|---|---|---|---|---|
Age (yrs) | 59.9 ± 1.93 | 55.6 ± 2.21 | 61.57 ± 2.05 | 58.07 ± 1.45 | ||
Sex (% Female) | 67 | 63 | 70 | 67 | ||
Height (m) | 1.64 ± 0.017 | 1.62 ± 0.017 | 1.6 ± 0.018 | 1.62 ± 0.011 | 0.0367 | |
Weight (kg) | 66.3 ± 2.07 | 71.80 ± 2.07 | 78.7 ± 2.21aaa | 84.5 ± 2.1aaa,bbbb | 0.2671 | |
BMI (kg/m2) | 24.94 ± 0.948 | 27.34 ± 0.767 | 31.27 ± 0.917aaa,b | 32.28 ± 0.91aaa,bbb | 0.276 | |
Diabetes duration (months) | 0.0 | 41.03 ± 4.46 | 53.97 ± 4.97 | 85.13 ± 6.06bbb,ccc | 0.6125 |
Data expressed are means ± SEM with n = 30 after Shapiro Wilk normality test has been performed. Data were analyzed by one-way ANOVA followed by Tukey's multiple post hoc test. a,b,c p < 0.05 vs Control, DM and DNP group respectively. Key: Diabetic without neuropathy (DM); Diabetic painful neuropathy (DNP); Diabetes neuropathy without pain (DN); Eta squared (R2); Body mass index (BMI).